Remedee is the next generation pain relief offering a new and individualized therapy to every patient.
Remedee Labs has raised €23M across 2 funding rounds from 6 investors, most recently a Series A round in Dec 2022. Based in Grenoble, France; founded 2012; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-12-06 | Series A | €12M | BPI,Generali France,Habert Dassault Finance,HCVC,Private Investors | View deal → |
| 2019-10-01 | Series A | €11M | Hardware Club | View deal → |
